Shirley C Hubbard

This inventor holds 5 USPTO granted patents. Top assignees: Genzyme Corporation, University of Iowa Research Foundation. Active years: 1998-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirley C Hubbard. Retrieved from https://idiyas.com/inventor/shirley-c-hubbard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 8.6

ph-index = 5

Forward Citations = 229(Granted Patents)

Company Filing History:

University of Iowa Research Foundation

patents

where one patent can have more than one assignee

Years Active: 1998-2002

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6383814 - Cationic amphiphiles for intracellular delivery of therapeutic molecules (2002-05-07),

2. 5935936 - Compositions comprising cationic amphiphiles and co-lipids for (1999-08-10),

3. 5840710 - Cationic amphiphiles containing ester or ether-linked lipophilic groups (1998-11-24),

4. 5767099 - Cationic amphiphiles containing amino acid or dervatized amino acid (1998-06-16),

5. 5747471 - Cationic amphiphiles containing steroid lipophilic groups for (1998-05-05),

Title: The Innovative Contributions of Shirley C. Hubbard

Introduction

Shirley C. Hubbard is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of therapeutic delivery systems, holding a total of 5 patents. Her work focuses on the development of cationic amphiphiles, which play a crucial role in the intracellular delivery of therapeutic molecules.

Latest Patents

Among her latest patents, one notable invention is titled "Cationic amphiphiles for intracellular delivery of therapeutic molecules." This patent describes compositions that comprise one or more neutral co-lipids and a cationic amphiphile. The therapeutic compositions are prepared by contacting a therapeutically active molecule with a dispersion of neutral co-lipid(s) and amphiphile(s). These innovative compositions have the potential to enhance the effectiveness of therapeutic treatments.

Career Highlights

Shirley has had a distinguished career, working with reputable organizations such as Genzyme Corporation and the University of Iowa Research Foundation. Her experience in these institutions has allowed her to advance her research and contribute to the development of new therapeutic solutions.

Collaborations

Throughout her career, Shirley has collaborated with notable individuals in her field, including David J. Harris and Edward R. Lee. These collaborations have further enriched her work and expanded the impact of her inventions.

Conclusion

Shirley C. Hubbard's innovative work in the field of therapeutic delivery systems exemplifies her dedication to advancing medical science. Her contributions continue to influence the development of effective treatment methods.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]